Avocado and Mango Trial Shows 8-Week Vascular Gains

Cardiovascular risk profiles often improve through modest, targeted additions rather than radical restriction. In a controlled trial involving adults with prediabetes, participants consumed one whole avocado and one cup of fresh mango daily for eight weeks. The protocol yielded measurable gains in flow-mediated dilation and diastolic blood pressure, showing particular efficacy among male participants.

Crucially, these vascular improvements arrived without measurable weight gain or increases in total energy intake. The trial mechanics indicate that the co-ingestion of monounsaturated fats from avocado alongside the specific polyphenolic profile of mango supports endothelial nitric oxide bioavailability. Rather than offsetting metabolic markers through excess carbohydrates, the combination stabilized peripheral vascular resistance.

When you parse dietary feedback from consumer health applications, keep in mind that most algorithms still rely on isolated macronutrient counts. You can use your own cuff readings and blood panels to evaluate specific dietary inclusions across eight-week windows, rather than relying solely on automated food-logging scores that reduce whole foods to simple carbohydrate liabilities.